| Ronald L Petrin, RPH | |
|
209 Route 101, Bedford, NH 03110-5440 | |
| (603) 472-3919 | |
| Not Available |
| Full Name | Ronald L Petrin |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 209 Route 101, Bedford, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386757748 | NPI | - | NPPES |
| 51 | Other | NH | NH BOARD OF PHARMACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1951 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ronald L Petrin, RPH 209 Route 101, Bedford, NH 03110-5440 Ph: (603) 472-3919 | Ronald L Petrin, RPH 209 Route 101, Bedford, NH 03110-5440 Ph: (603) 472-3919 |
News Archive
Gallup, the global polling organization, and Healthways, the worldwide leader in well-being improvement, today jointly revealed new data showing that chronic conditions, such as obesity, diabetes and cancer are costing the UK economy 21.6 billion pounds a year in lost productivity.
Actress Angelina Jolie made headlines in May when she revealed she underwent a preventive double mastectomy to reduce her risk of cancer.
The development of oral cancer drugs as a modality therapy over the last decade has highlighted the problem of non-adherence. Only cancer drugs that are taken can actually work.
Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.
NovaBay Pharmaceuticals, Inc. announced today that its development partner, Alcon Research, Ltd., has concluded its proof of concept clinical trial of NovaBay's patented lead Aganocide compound, NVC-422 for the treatment of viral conjunctivitis a highly contagious eye infection for which there are currently no marketed products.
› Verified 4 days ago
Dr. Falon Anne Kaspszak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 Route 101, Bedford, NH 03110 Phone: 603-472-3919 Fax: 603-472-7448 | |
Kim Ahearn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 Route 101, Bedford, NH 03110 Phone: 603-472-3919 Fax: 603-472-7448 | |
Laurie Keith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 258 Wallace Rd, Bedford, NH 03110 Phone: 603-472-5847 | |
Nicholas Driscoll, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 258 Wallace Rd, Bedford, NH 03110 Phone: 603-472-5847 | |
Mrs. Ronda Lee Hatin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Colby Ct, Bedford, NH 03110 Phone: 603-622-2320 | |
Mrs. Lori Ellen Connors, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 S River Rd, Bedford, NH 03110 Phone: 603-263-0062 | |
Ms. Narmin Pirmohamed, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Technology Dr, Bedford, NH 03110 Phone: 603-626-6200 |